Duality | Jotup

BeiGene and DualityBio Announce Partnership to Advance Differentiated Antibody Drug Conjugate (ADC) Therapy for Solid Tumors

Retrieved on:

Monday, July 10, 2023

Oncology, Health, Research, Pharmaceutical, Science, Biotechnology, ADC, BGNE, SSE, Spacecraft, Partnership, IND, Doctor of Philosophy, Patient, Safety, Pharmaceutical industry, Fine chemical, BeiGene, Duality

BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company, and DualityBio, a next-generation ADC company, today announced an agreement for BeiGene to acquire an exclusive option for a global clinical and commercial license to an investigational, preclinical ADC therapy for patients with select solid tumors.

Key Points:

BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company, and DualityBio, a next-generation ADC company, today announced an agreement for BeiGene to acquire an exclusive option for a global clinical and commercial license to an investigational, preclinical ADC therapy for patients with select solid tumors.
“With one of the industry’s leading global oncology research teams, we are investing in highly impactful therapeutic modalities such as ADCs that complement our dynamic and growing pipeline in solid tumors,” said Lai Wang, Ph.D., Global Head of R&D at BeiGene.
“We are excited to partner with BeiGene to accelerate the development of this asset.
Upon exercising its option, BeiGene will hold global clinical, manufacturing, and commercial rights while DualityBio will perform all research activities through IND-enabling studies and support future IND filings by BeiGene.

Adcendo Appoints Experienced Drug Developer Dr. Lone H. Ottesen as Chief Medical Officer

Retrieved on:

Tuesday, June 20, 2023

GSK, Drug development, Research, CMO, Doctor of Philosophy, AstraZeneca, Eisai, MD, Patient, Cancer, Duality, ADC, Spacecraft, Aarhus University, Health, Lone, Pharmaceutical industry, Nursing, Fine chemical

Dr. Ottesen is a highly accomplished drug developer with extensive global clinical development experience across oncology and immune-oncology with a track record of more than 20 years in both early- and late-phase clinical development.

Key Points:

Dr. Ottesen is a highly accomplished drug developer with extensive global clinical development experience across oncology and immune-oncology with a track record of more than 20 years in both early- and late-phase clinical development.
Dr. Ottesen held roles of increasing seniority in Global Oncology Development at GSK, Eisai and most recently at AstraZeneca, where
she was Global Clinical Head in Late-Stage Clinical Development.
She joins Adcendo from Circio, formerly known as Targovax, where she was Chief Medical Officer and previously Chief Development Officer.
Lone Ottesen, incoming Chief Medical Officer at Adcendo, said "ADCs are at the forefront of a paradigm shift in cancer chemotherapy, and I am excited to join Adcendo to shape its IND-enabling activities and clinical plans.

Adcendo Appoints Experienced Drug Developer Dr. Lone H. Ottesen as Chief Medical Officer

Retrieved on:

Tuesday, June 20, 2023

Dr. Ottesen is a highly accomplished drug developer with extensive global clinical development experience across oncology and immune-oncology with a track record of more than 20 years in both early- and late-phase clinical development.

Key Points:

Dr. Ottesen is a highly accomplished drug developer with extensive global clinical development experience across oncology and immune-oncology with a track record of more than 20 years in both early- and late-phase clinical development.
Dr. Ottesen held roles of increasing seniority in Global Oncology Development at GSK, Eisai and most recently at AstraZeneca, where
she was Global Clinical Head in Late-Stage Clinical Development.
She joins Adcendo from Circio, formerly known as Targovax, where she was Chief Medical Officer and previously Chief Development Officer.
Lone Ottesen, incoming Chief Medical Officer at Adcendo, said "ADCs are at the forefront of a paradigm shift in cancer chemotherapy, and I am excited to join Adcendo to shape its IND-enabling activities and clinical plans.

Lux Revamp Delivers Aesthetic Laser Solutions in Neptune Beach, FL, Featuring the Astanza Duality Laser

Retrieved on:

Wednesday, June 7, 2023

Duality, Blemish, Love, Skin, Laser, Ink, Health care

DALLAS, June 07, 2023 (GLOBE NEWSWIRE) -- Lux Revamp is a rising laser practice in Neptune Beach, Florida that specializes in removing unwanted tattoos and skin blemishes using the advanced Astanza Duality laser.

Key Points:

DALLAS, June 07, 2023 (GLOBE NEWSWIRE) -- Lux Revamp is a rising laser practice in Neptune Beach, Florida that specializes in removing unwanted tattoos and skin blemishes using the advanced Astanza Duality laser.
Lux Revamp is officially opening its doors in June and provides a wide range of aesthetic services, including laser tattoo removal, vascular lesion removal, and pigmented lesion removal, and injectables.
Lux Revamp also uses the Zimmer Cryo cooling machine, a superior skin-numbing solution, for maximum patient comfort and skin alleviation.
“The Lux Revamp team is highly skilled and committed to the success of their clients,” said Bryce Fisher, Astanza Account Representative.

Duality Featured on Fast Company’s 2023 World Changing Ideas List

Retrieved on:

Monday, May 22, 2023

Earlier this month, Fast Company named Duality to its 2023 list of World Changing Ideas.

Key Points:

Earlier this month, Fast Company named Duality to its 2023 list of World Changing Ideas.
Duality was named a Finalist in the Rapid Response category and received Honorable Mentions in two additional categories, Small Business and On The Rise.
View the full release here: https://www.businesswire.com/news/home/20230522005065/en/
Fast Company's recognition highlights the key role of digital twin-based simulation in solving complex real-world problems.
Since debuting this project in November 2022, Duality has continued their work in response planning and has expanded their scope into large-scale climate disasters.

Nena’s Skin Studio Brings Advanced Laser Tattoo Removal and More to Bethel Park, PA Featuring the Astanza Duality Laser

Retrieved on:

Tuesday, April 25, 2023

Duality, Zimmer, Ink, Skin, Risk, Scalp, Nightclub, Mineral oil

BETHEL PARK, Pa., April 25, 2023 (GLOBE NEWSWIRE) -- Nena's Skin Studio is holding its grand opening on Monday, May 1, 2023, in Bethel Park, PA.

Key Points:

BETHEL PARK, Pa., April 25, 2023 (GLOBE NEWSWIRE) -- Nena's Skin Studio is holding its grand opening on Monday, May 1, 2023, in Bethel Park, PA.
They include advanced laser tattoo removal featuring the Astanza Duality, permanent makeup artistry, and scalp micropigmentation.
I believe laser tattoo removal is more than just an eraser – it’s a corrective tool that can help transform existing ink and makeup.”
Nena’s Skin Studio uses the Astanza Duality Q-switched Nd:YAG laser to eliminate unwanted tattoos.
“Astanza is excited to partner with this growing practice as they positively transform people’s skin.”
To celebrate its grand opening, Nena’s Skin Studio is offering 15% off laser tattoo removal treatments during the month of May.

Laser 180 Brings Advanced Laser Tattoo and Hair Removal to Latrobe, PA Featuring the Astanza Duality and Asclepion MeDioStar® Lasers

Retrieved on:

Monday, April 3, 2023

Duality, Asclepieion, Hair, YAG, Skin, City, Carbon, 3D printing

LATROBE, Pa., April 03, 2023 (GLOBE NEWSWIRE) -- Laser 180 is a rising aesthetic practice in Latrobe, Pennsylvania, that offers various laser services, including laser tattoo removal, laser hair removal, and carbon laser facials.

Key Points:

LATROBE, Pa., April 03, 2023 (GLOBE NEWSWIRE) -- Laser 180 is a rising aesthetic practice in Latrobe, Pennsylvania, that offers various laser services, including laser tattoo removal, laser hair removal, and carbon laser facials.
The Astanza Duality is primarily used for laser tattoo removal and is a state-of-the-art Q-switched Nd:YAG system that produces 1064 nm and 532 nm wavelengths.
The MeDioStar® is a revolutionary diode laser that produces long-lasting hair removal results.
“Laser 180 is reshaping the aesthetic industry in Latrobe and surrounding cities,” said Joshua Walsh, Astanza Account Representative.

DUALITY AND TEL AVIV SOURASKY MEDICAL CENTER REVOLUTIONIZES RESEARCH AGILITY IN HEALTHCARE

Retrieved on:

Tuesday, April 4, 2023

HOBOKEN, N.J., April 4, 2023 /PRNewswire/ -- Duality Technologies, the leader in secure data collaboration for enterprises, today announced its partnership with Tel Aviv Sourasky Medical Center (TASMC); the partnership enables TASMC's partners network to easily collaborate on sensitive data while preserving privacy of patients and complying with regulation. Duality's platform was successfully piloted by TASMC, proving that Real-World Data analysis yields accurate results when performed on data protected by Duality Platform.

Key Points:

Duality's platform was successfully piloted by TASMC, proving that Real-World Data analysis yields accurate results when performed on data protected by Duality Platform.
"Tel Aviv Sourasky Medical Center is world renown for top quality medical care and for leadership in technology innovation.
To gain such insights medical centers often must team up with other medical centers to build statistically significant cohorts and with industrial partners that work on medical research.
We are excited by the partnering with Tel Aviv Sourasky Medical Center, as it unlocks a new, agile and secure, way for organizations to collaborate on healthcare data, while complying with regulation," commented Rina Shainski, chairwoman and co-founder at Duality.

Envision Laser Removal Delivers Full-Spectrum Tattoo Removal in Port Charlotte, FL with Astanza Trinity TSR Laser Upgrade

Retrieved on:

Tuesday, March 28, 2023

Eternity, Duality, Laser, PORT, Trinity, 3D printing

PORT CHARLOTTE, Fla., March 27, 2023 (GLOBE NEWSWIRE) -- Envision Laser Removal recently upgraded its laser technology to the Astanza Trinity TSR laser to remove all multicolored tattoos completely.

Key Points:

PORT CHARLOTTE, Fla., March 27, 2023 (GLOBE NEWSWIRE) -- Envision Laser Removal recently upgraded its laser technology to the Astanza Trinity TSR laser to remove all multicolored tattoos completely.
The leading Port Charlotte tattoo removal provider opened with the Astanza Duality in March 2022 and saw tremendous success quickly.
Owners Eric and Susan Wells decided to add the Astanza Eternity, thus completing the Astanza Trinity TSR system, to take Envision Laser Removal’s success to the next level by offering full-spectrum tattoo removal results.
Together, the Duality and Eternity create the Astanza Trinity TSR, a triple-wavelength tattoo removal system comprised of two fully powered lasers.

Oakville, Connecticut Laser Tattoo Removal Practice, Tarnished, Upgrades Technology to the Astanza Trinity Full-Spectrum Laser

Retrieved on:

Monday, March 6, 2023

Eternity, Trinity, Tarnished, Duality, Ruby laser, Skin, 3D printing

OAKVILLE, Conn., March 06, 2023 (GLOBE NEWSWIRE) -- Tarnished , a professional laser tattoo removal practice in the renowned Brass City Tattoo Shop , recently upgraded its Astanza Duality laser to the Astanza Trinity.

Key Points:

OAKVILLE, Conn., March 06, 2023 (GLOBE NEWSWIRE) -- Tarnished , a professional laser tattoo removal practice in the renowned Brass City Tattoo Shop , recently upgraded its Astanza Duality laser to the Astanza Trinity.
The laser provider opened its doors in 2021 and has since become a staple name in Connecticut’s tattoo removal scene thanks to its superior tattoo removal and modification services.
Tarnished upgraded its Duality laser by adding the Eternity Q-switched ruby laser, completing the Astanza Trinity system to deliver full-spectrum removal for all multicolored tattoos.
“They’ve done amazing work, and I have no doubts their upgrade to the Trinity will solidify their business as the leading laser tattoo removal provider in Oakville.”